期刊文献+

炭疽芽孢杆菌A16R株无菌培养滤液的蛋白质组学分析

Proteomic analysis of Bacillus anthracis A16R strain sterile culture filtrate
原文传递
导出
摘要 目的:初步分析由我国炭疽疫苗株A16R所生产的无菌培养滤液中的主要成分。方法:运用免疫蛋白质组学的手段,从炭疽A16R疫苗株无菌培养滤液的二维凝胶电泳中选择与保护性抗体结合和不与该血清结合但丰度高的蛋白质点,进行质谱鉴定和信号肽分析。结果:共选择73个点,从炭疽芽孢杆菌数据库中鉴定出66个。在66个点中,有43个点与保护性血清结合;23个为高丰度蛋白,不与该血清结合。在与保护性血清结合的43个点中,13个点为不同大小的PA分子,其中相对分子质量83×103和63×103占主导,相对分子质量较小的片段仅4个。其余成分包括炭疽表面蛋白EA1、Sap、胶原黏附蛋白、伴侣分子DnaK等。结论:我们制备的炭疽无菌培养滤液中含有PA成分,PA是炭疽疫苗的重要保护性抗原。但PA以外的其他成分在抗炭疽免疫中起何种作用,是否参与诱发机体免疫应答有待进一步研究。 Objective:To analyze the protein profile of sterile culture filtrate from a Bacillus anthracis vaccine A16R (pXO1^+ , pXO2^- ) strain. Methods :Two-dimensional gel electrophoresis (2-DGE) and immunoblot using protective rabbit polyclonal antisera were used to select cross-reactive and high-abundance spots, which were identified by MALDI-TOF- MS, then signal peptide of identified proteins was analyzed. Results :A total of 66 spots identified from 73 spots selected represented 28 protein entries, including 43 spots reacting with antisera and 23 high-abundance non-cross-reactive spots. Of the 43 cross-reactive spots, 13 were PA molecules of different sizes, with the 83×10^3 and 63×10^3 species being dominant. Only four protein spots were low relative molecular mass fragments such as 20×10^3 and 50×10^3. The rest of the cross-reactive proteins included protein entries related to protein fate (chaperone protein DnaK and collagen adhesive protein), protein entries of cell envelope (S-layer protein EA1 precursor, S-layer protein Sap precursor). Conclusion: Our findings indicate that PA is present in B. anthracis vaccine A16R strain sterile culture filtrate and PA is the important protective component of anthrax vaccine. Further work will be required to find ont whether other components such as S-layer proteins, DnaK, collagen adhesive protein also play important roles in inducing immune response against anthrax.
出处 《军事医学科学院院刊》 CSCD 北大核心 2009年第1期6-9,13,共5页 Bulletin of the Academy of Military Medical Sciences
基金 国家"973"计划项目(2002CB513208)
关键词 炭疽 炭疽疫苗 A16R株 无菌培养滤液 二维凝胶电泳 免疫蛋白质组学 anthrax anthrax vaccine Bacillus anthracis A16R strain sterile culture filtrate two-dimensional gel eletrophoresis immunoproteomics
  • 相关文献

参考文献10

  • 1庄汉澜,董梅.炭疽免疫预防研究的现状及动向[J].传染病信息,2006,19(2):51-52. 被引量:3
  • 2董梅,马丽娟,张松乐,张良艳,郭习勤,邢丽,杨海荣,王希良.炭疽杆菌培养上清液抗原的制备及免疫保护效果测定[J].免疫学杂志,2006,22(3):321-324. 被引量:3
  • 3庄汉澜 胡娟 郑愉 等.炭疽保护性抗原的理化和免疫原性的初步观察[J].科学通报,1987,(4):160-160.
  • 4Flick-Smith HC, Walker N J, Gibson P,et al. A recombinant carboxyterminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection [ J ]. Infect Immun, 2002,70(3): 1653 -1656.
  • 5Whiting GC, Rijpkema S, Adams T,et al. Characterization of adsorbed anthrax vaccine by two-dimensional gel eletrophoresis[ J]. Vaccine,2004,22 (31-32) : 4245 - 4251.
  • 6Welkos S,Friedlander AM. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccine in mice [ J]. Microb Pathog, 1988,5 (2) :127 - 139.
  • 7Brossier F, Levy M, Mock M. Anthrax spores make an essential contribution to vaccine efficacy [ J ]. Infect Immun,2002,70 ( 2 ) : 661 - 664.
  • 8Chabot D J, Scorpio A, Tobery SA, et al. Anthrax capsule vaccine protects against experimental infection [ J ]. Vaccine, 2004, 23 ( 1 ) : 43 - 47.
  • 9Ariel N, Zvi A, Makarova KS, et al. Genome-based bioirfformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens [ J ]. Infect Immun,2003,71 ( 8 ) :4563 - 4579.
  • 10Williams RC, Reeds ML, Jaeobs MF, et al. Production of Bacillus anthracis protective antigen is dependent on the extracellular chaperone, PrsA[J]. J Biol Chem, 2003,278 (20) : 18056 - 18062.

二级参考文献13

  • 1庄汉澜.炭疽[M]//唐家琪.自然疫源性疾病.北京:科学出版社,2005:913~939.
  • 2庄汉澜 胡娟 郑愉 等.炭疽保护性抗原的理化和免疫原性的初步观察[J].科学通报,1987,(4):160-160.
  • 3Tumbull PCB. Anthrax vaccine: past, present and future[J] . Vaccine,1991, 9:533-539.
  • 4Ffiedlander AM, Welkos SL, Ivins BE. Anthrax vaccine[J] . Curt Top Microbiol Immunol, 2002, 271:33-60.
  • 5Moayeri M, Leppla SH. The roles of anthrax toxin in pathogenesis[J] .Curr Opin Microbiol, 2004,7(1):19-24.
  • 6Inglesby TV,O'Toole T,Henderson DA,et al.Anthrax as a biological weapon,2002:updated recommendations for management[J].JAMA,2002,287 (17):2 236-2 252.
  • 7Chabot DJ,Scorpio A,Tobery SA,et al.Anthrax capsule vaccine protects against experimental infection[J].Vaccine,2004,23 (1):43-47.
  • 8Oggioni MR,Ciabattini A,Cuppone AM,et al.Bacillus spores for vaccine delivery[J].Vaccine,2003,21 (Suppl2):S96-S101.
  • 9Brossier F,Levy M,Mock M.Anthrax spores make an essential contribution to vaccine efficacy[J].Infect Immun,2002,70 (2):661-664.
  • 10Demicheli V,Rivetti D,Deeks JJ,et al.The effectiveness and safety of vaccines against human anthrax:a systematic review[J].Vaccine,1998,16 (9/10):880-884.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部